At the news
? NEUTRALIMPACT 2/10 144 filed Oct 8, 2026 at 18:06 ET
Stephen Neeleman, an officer and director of HealthEquity, filed a Form 144 notice to sell 1,095 shares of common stock valued at approximately $99,815. The shares were acquired through restricted stock vesting between 2023 and 2025. The filing states the sale is a mandatory 'sell to cover' transaction for tax withholding obligations, not a discretionary trade.
- Insider Stephen Neeleman (Officer, Director) filed Form 144 to sell 1,095 shares
- Estimated proceeds: ~$99,815 based on recent sale price of ~$91.16/share
- Shares acquired via restricted stock vesting on 03/29/2023 (410 shares), 03/27/2024 (300 shares), and 04/02/2025 (385 shares)
- Filing explicitly states sale is a mandatory 'sell to cover' transaction for tax withholding, not a discretionary trade
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access